Aksoylar, Serap <br/><br/>
Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.  [electronic resource] 

 -  Pediatric hematology and oncology  Mar 2004 
 - 115-23 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0888-0018 
<br/><br/><label>Standard No.: </label>10.1080/08880010490277321  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amikacin--administration & dosage<br/>Anti-Bacterial Agents--therapeutic use<br/>Drug Therapy, Combination--therapeutic use<br/>Fever--drug therapy<br/>Fungi--isolation & purification<br/>Gram-Negative Bacteria--isolation & purification<br/>Gram-Positive Bacteria--isolation & purification<br/>Hematologic Neoplasms--complications<br/>Humans<br/>Infections--microbiology<br/>Meropenem<br/>Neoplasms--complications<br/>Netilmicin--administration & dosage<br/>Neutropenia--drug therapy<br/>Penicillanic Acid--administration & dosage<br/>Piperacillin--administration & dosage<br/>Tazobactam<br/>Thienamycins--administration & dosage